HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yue Qiu Selected Research

Messenger RNA (mRNA)

1/2024Exosome-mediated communication between gastric cancer cells and macrophages: implications for tumor microenvironment.
12/2023Celastrol suppresses human pancreatic cancer via m6A-YTHDF3-mediated downregulation of Claspin and Bcl-2.
5/2023Epigenetically silenced lncRNA SNAI3-AS1 promotes ferroptosis in glioma via perturbing the m6A-dependent recognition of Nrf2 mRNA mediated by SND1.
1/2022ITGA5 Promotes Tumor Progression through the Activation of the FAK/AKT Signaling Pathway in Human Gastric Cancer.
1/2020Coexpression Network Analysis of Genes Related to the Characteristics of Tumor Stemness in Triple-Negative Breast Cancer.
8/2015Decreased mRNA and protein expression of TWIST1 in myocardial tissue of fetuses with ventricular septal defects.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yue Qiu Research Topics

Disease

56Neoplasms (Cancer)
05/2024 - 08/2012
15Breast Neoplasms (Breast Cancer)
05/2023 - 05/2015
13Inflammation (Inflammations)
10/2023 - 06/2011
10Neoplasm Metastasis (Metastasis)
03/2024 - 12/2014
9Infections
12/2023 - 01/2018
8Glioma (Gliomas)
05/2023 - 08/2015
8Stomach Neoplasms (Stomach Cancer)
01/2023 - 01/2013
7Melanoma (Melanoma, Malignant)
04/2022 - 11/2015
6Fibrosis (Cirrhosis)
12/2023 - 01/2021
5Deafness (Deaf Mutism)
02/2024 - 01/2020
5Malaria
12/2023 - 01/2019
4Mitochondrial Diseases (Mitochondrial Disease)
11/2023 - 01/2019
4Reperfusion Injury
03/2023 - 05/2013
4Body Weight (Weight, Body)
01/2023 - 01/2019
4Cognitive Dysfunction
01/2023 - 09/2014
3Sarcoma (Soft Tissue Sarcoma)
05/2024 - 01/2022
3Pancreatic Neoplasms (Pancreatic Cancer)
12/2023 - 10/2021
3Stroke (Strokes)
12/2023 - 01/2023
3Auditory neuropathy
11/2023 - 01/2023
3Epilepsy (Aura)
11/2023 - 01/2020
3Hearing Loss (Hearing Impairment)
02/2023 - 01/2021
3Squamous Cell Carcinoma of Head and Neck
02/2023 - 01/2021
3Hepatocellular Carcinoma (Hepatoma)
01/2023 - 02/2007
3Congenital Heart Defects (Congenital Heart Defect)
01/2023 - 05/2017
3Lymphatic Metastasis
01/2023 - 01/2021
3Psoriasis (Pustulosis Palmaris et Plantaris)
11/2022 - 11/2016
3Atherosclerosis
04/2022 - 10/2021
3Pre-Eclampsia (Preeclampsia)
07/2018 - 11/2014
3Pain (Aches)
06/2018 - 07/2009
2Prostatic Neoplasms (Prostate Cancer)
03/2024 - 01/2024
2Diabetic Cardiomyopathies
12/2023 - 01/2021
2Bone Resorption
01/2023 - 01/2020
2Congenital Abnormalities (Deformity)
01/2023 - 01/2021
2Alzheimer Disease (Alzheimer's Disease)
01/2023 - 09/2014
2Autoimmune Diseases of the Nervous System
01/2023 - 01/2022
2Osteoporosis
01/2023 - 01/2020
2Cardiomegaly (Heart Hypertrophy)
01/2023 - 03/2020

Drug/Important Bio-Agent (IBA)

16Proteins (Proteins, Gene)FDA Link
01/2024 - 06/2011
15Liposomes (Liposome)IBA
01/2022 - 05/2015
13Peptides (Polypeptides)IBA
02/2023 - 08/2015
12Therapeutic UsesIBA
10/2022 - 01/2016
9Paclitaxel (Taxol)FDA LinkGeneric
01/2022 - 05/2015
7MicroRNAs (MicroRNA)IBA
03/2024 - 01/2017
7Long Noncoding RNAIBA
05/2023 - 07/2018
6Biomarkers (Surrogate Marker)IBA
05/2024 - 09/2014
6Messenger RNA (mRNA)IBA
01/2024 - 08/2015
6Doxorubicin (Adriamycin)FDA LinkGeneric
03/2022 - 05/2016
5LipidsIBA
01/2024 - 04/2018
5citronellalIBA
12/2023 - 01/2021
5VaccinesIBA
12/2023 - 01/2020
5LigandsIBA
12/2023 - 05/2016
5IntegrinsIBA
01/2020 - 09/2015
4RNA (Ribonucleic Acid)IBA
12/2023 - 01/2020
4C-Reactive ProteinIBA
11/2023 - 11/2014
4CalciumIBA
11/2023 - 01/2022
4Anti-Bacterial Agents (Antibiotics)IBA
10/2023 - 01/2020
4AlbuminsIBA
07/2023 - 10/2020
4MicellesIBA
07/2023 - 09/2019
4Cell-Penetrating PeptidesIBA
04/2018 - 11/2015
3N-methyladenosineIBA
03/2024 - 01/2021
3CollagenIBA
12/2023 - 05/2015
3Oxaliplatin (Eloxatin)FDA LinkGeneric
11/2023 - 08/2020
3InflammasomesIBA
11/2023 - 11/2020
3Reactive Oxygen Species (Oxygen Radicals)IBA
09/2023 - 01/2022
3Small Interfering RNA (siRNA)IBA
03/2023 - 07/2018
3Transferrin (beta 2 Transferrin)IBA
01/2023 - 05/2016
3AntioxidantsIBA
01/2023 - 01/2021
3Dexamethasone (Maxidex)FDA LinkGeneric
10/2022 - 01/2021
3EnzymesIBA
03/2022 - 01/2020
3Transcription Factors (Transcription Factor)IBA
01/2022 - 05/2017
3Adenosine Triphosphate (ATP)IBA
11/2020 - 01/2019
2Circular RNAIBA
04/2024 - 03/2024
2Diphtheria ToxinIBA
02/2024 - 01/2021
2Immunotoxins (Immunotoxin)IBA
02/2024 - 02/2023
225-hydroxyvitamin DIBA
01/2024 - 01/2020
2Monoterpenes (Monoterpenoids)IBA
12/2023 - 04/2022
2Particulate MatterIBA
12/2023 - 01/2023
2Glutathione (Reduced Glutathione)IBA
12/2023 - 09/2019
2OzoneIBA
12/2023 - 01/2023
2Sulfur DioxideIBA
12/2023 - 01/2023
2Nitrogen DioxideIBA
12/2023 - 01/2023
2Carbon MonoxideIBA
12/2023 - 01/2023
2Cisplatin (Platino)FDA LinkGeneric
11/2023 - 10/2021
2Actins (F Actin)IBA
11/2023 - 01/2021
2AntigensIBA
07/2023 - 05/2021
2human ERBB2 proteinIBA
02/2023 - 01/2022
2Hormones (Hormone)IBA
02/2023 - 01/2022
2Epidermal Growth Factor (EGF)IBA
02/2023 - 01/2021
2AntibodiesIBA
02/2023 - 01/2020
2ErbB Receptors (EGF Receptor)IBA
02/2023 - 01/2021
2Ferritins (Ferritin)IBA
01/2023 - 12/2021
2IronIBA
01/2023 - 12/2021
2LipopolysaccharidesIBA
01/2023 - 11/2020

Therapy/Procedure

34Therapeutics
02/2024 - 01/2016
8Immunotherapy
05/2024 - 11/2018
7Drug Therapy (Chemotherapy)
03/2022 - 08/2015
5Radiotherapy
03/2024 - 08/2012
4Aftercare (After-Treatment)
10/2023 - 01/2019
3Chinese Traditional Medicine (Traditional Chinese Medicine)
01/2023 - 12/2021
3Endovascular Aneurysm Repair
01/2022 - 12/2020